Toward achieving optimal response: understanding and managing antidepressant side effects
about
Pharmacological approaches to the challenge of treatment-resistant depressionTreating depression within the HIV "medical home": a guided algorithm for antidepressant management by HIV cliniciansA generalist's guide to treating patients with depression with an emphasis on using side effects to tailor antidepressant therapyEfficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial.A randomized controlled longitudinal naturalistic trial testing the effects of automatic self transcending meditation on heart rate variability in late life depression: study protocol.Preventing relapse in recurrent depression using mindfulness-based cognitive therapy, antidepressant medication or the combination: trial design and protocol of the MOMENT study.Relapse prevention in major depressive disorder: Mindfulness-based cognitive therapy versus an active control condition.A randomized, double-blind, placebo-controlled study of flexible doses of levomilnacipran ER (40-120 mg/day) in patients with major depressive disorder.Safety and tolerability of levomilnacipran ER in major depressive disorder: results from an open-label, 48-week extension study.The efficacy of psychotherapy, pharmacotherapy and their combination on functioning and quality of life in depression: a meta-analysisCYP2D6 P34S Polymorphism and Outcomes of Escitalopram Treatment in Koreans with Major Depression.Imagine your mood: Study design and protocol of a randomized controlled micro-trial using app-based experience sampling methodology to explore processes of change during relapse prevention interventions for recurrent depression.
P2860
Q26798241-F8C34E91-3B83-4B9A-8786-092E87376C19Q26823842-D8F2F1D7-C87D-4203-9EE3-C8E73340C975Q33884174-AE007EA3-349D-494F-AC96-87CF58ADDD6CQ33909349-174B5F2D-0770-4CBA-AC16-E15D4487BABBQ34100315-455DFF3C-2B7A-4C56-AA9C-E723F17B9C81Q34394278-53495F57-96F7-4FA6-B89C-A3AECC066EA3Q36063613-39631A01-DEE7-4E24-BC2B-3A87F07421BEQ37077152-87E601E0-546D-44D1-9850-3BA68110E28AQ37177212-70BC1982-2795-40F6-9DFC-8CD322F0F14FQ37593438-BF41565A-E1E8-4589-91B9-6ABF23959B3AQ41892920-FE9A7003-8609-4B7D-99CD-1630350BFC5EQ52562530-C5EA0003-D377-4D89-9490-9ABEBF3F5F57
P2860
Toward achieving optimal response: understanding and managing antidepressant side effects
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Toward achieving optimal response: understanding and managing antidepressant side effects
@ast
Toward achieving optimal response: understanding and managing antidepressant side effects
@en
type
label
Toward achieving optimal response: understanding and managing antidepressant side effects
@ast
Toward achieving optimal response: understanding and managing antidepressant side effects
@en
prefLabel
Toward achieving optimal response: understanding and managing antidepressant side effects
@ast
Toward achieving optimal response: understanding and managing antidepressant side effects
@en
P2093
P2860
P1476
Toward achieving optimal response: understanding and managing antidepressant side effects
@en
P2093
Jonathan E Alpert
Karen Kelly
Michael Posternak
P2860
P304
P577
2008-01-01T00:00:00Z